2018
DOI: 10.1016/j.cyto.2017.10.020
|View full text |Cite
|
Sign up to set email alerts
|

Angiogenic factor screening in women with mild preeclampsia – New and significant proteins in plasma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(21 citation statements)
references
References 49 publications
1
20
0
Order By: Relevance
“…Since FS is a pro-angiogenic molecule, the downregulation of FS in PE is plausible , in view of the decreased angiogenesis (Turcotte et al, 2017). Additionally, our findings are supported by Charkiewicz et al (2018) who reported that pro-angiogenic factors (VEGF and PIGF) are downregulated, with a concurrent significant decline in FS expression in women with PE.…”
Section: Synthesissupporting
confidence: 88%
“…Since FS is a pro-angiogenic molecule, the downregulation of FS in PE is plausible , in view of the decreased angiogenesis (Turcotte et al, 2017). Additionally, our findings are supported by Charkiewicz et al (2018) who reported that pro-angiogenic factors (VEGF and PIGF) are downregulated, with a concurrent significant decline in FS expression in women with PE.…”
Section: Synthesissupporting
confidence: 88%
“…The mRNA LIF was selected through the jak-stat signaling pathway and ceRNA network in our research. Charkiewicz et al reported a statistically significant increase in the concentration of LIF in the plasma of women with PE [13]. The study launched by Zheng et al indicated a role for LIF in promoting trophoblast migration and invasion through uPAR and suggested it might be associated with the etiology of PE [36].…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported to negatively regulate tumor-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers [11], and also LIF withdrawal is reported to activate mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway [12]. Importantly, some studies found that LIF was high expression in preeclamptic patients [1315]. One study reported that LIF could regulate chondroitin sulfate proteoglycan 4 (CSPG4) expression to impact human trophoblast function [16].…”
Section: Introductionmentioning
confidence: 99%
“…Different studies have found that the mean PLGF level in preeclampsia is following 125 pg/ml at gestational age 20-37 weeks [8]: 95 pg/ml at midtrimester gestational age [9]; 38.7 pg/ml at 32-37 weeks gestation [10]; 54 pg/ml at 20-34 weeks gestation [11]; 83.75 pg/ml at 20-30 weeks gestation [12]; 239.75 pg/ml at 25-40 weeks’ gestation [13].…”
Section: Discussionmentioning
confidence: 99%